PuSH - Publication Server of Helmholtz Zentrum München: Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Reddy, N.R.* ; Maachi, H. ; Xiao, Y.* ; Simic, M.S.* ; Yu, W.* ; Tonai, Y.* ; Cabanillas, D.A.* ; Serrano-Wu, E.* ; Pauerstein, P.T.* ; Tamaki, W.* ; Allen, G.M.* ; Parent, A.V.* ; Hebrok, M. ; Lim, W.A.*

Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.

Science 386:eadl4793 (2024)

Publ. Version/Full Text

DOI

PMC

	Closed

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Immune homeostasis requires a balance of inflammatory and suppressive activities. To design cells potentially useful for local immune suppression, we engineered conventional CD4⁺ T cells with synthetic Notch (synNotch) receptors driving antigen-triggered production of anti-inflammatory payloads. Screening a diverse library of suppression programs, we observed the strongest suppression of cytotoxic T cell attack by the production of both anti-inflammatory factors (interleukin-10, transforming growth factor-β1, programmed death ligand 1) and sinks for proinflammatory cytokines (interleukin-2 receptor subunit CD25). Engineered cells with bespoke regulatory programs protected tissues from immune attack without systemic suppression. Synthetic suppressor T cells protected transplanted beta cell organoids from cytotoxic T cells. They also protected specific tissues from unwanted chimeric antigen receptor (CAR) T cell cross-reaction. Synthetic suppressor T cells are a customizable platform to potentially treat autoimmune diseases, organ rejection, and CAR T cell toxicities with spatial precision.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Immune Cells; Immunotherapy; Recognition; Challenges; Cancer

ISSN (print) / ISBN 0036-8075

e-ISSN 1095-9203

Journal Science

Quellenangaben Volume: 386, Issue: 6726, Article Number: eadl4793

Publisher American Association for the Advancement of Science (AAAS)

Publishing Place 1200 New York Ave, Nw, Washington, Dc 20005 Usa

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute for Diabetes und Organoid Technology (IDOT)

Grants Valhalla Foundation
NIH/NIDDK
NIH/NCI